MAM
Martingale Asset Management Portfolio holdings
AUM
$4.08B
This Quarter Return
+4.77%
1 Year Return
+20.69%
3 Year Return
+65.38%
5 Year Return
+128.32%
10 Year Return
+323.81%
AUM
$5.06B
AUM Growth
+$5.06B
(+12%)
Cap. Flow
+$431M
Cap. Flow
% of AUM
8.51%
Top 10 Holdings %
Top 10 Hldgs %
12.64%
Holding
914
New
94
Increased
351
Reduced
276
Closed
119
Top Buys
| 1 |
Intel
INTC
|
$19.3M |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
$18.5M |
| 3 |
J.M. Smucker
SJM
|
$18.3M |
| 4 |
AT&T
T
|
$15.3M |
| 5 |
BMS
Bemis
BMS
|
$15M |
Top Sells
| 1 |
Wells Fargo
WFC
|
$16M |
| 2 |
Hormel Foods
HRL
|
$11.9M |
| 3 |
Pfizer
PFE
|
$11.8M |
| 4 |
Jones Lang LaSalle
JLL
|
$10.8M |
| 5 |
AutoNation
AN
|
$10.7M |
Sector Composition
| 1 | Consumer Staples | 13.93% |
| 2 | Healthcare | 13.92% |
| 3 | Technology | 13.18% |
| 4 | Financials | 12.64% |
| 5 | Consumer Discretionary | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
126
Diversified Healthcare Trust
DHC
$903M
| $14.2M | 0.28% |
794,900
+117,110
| +17% | +$2.1M |
|
127
Baxter International
BAX
$12.1B
| $14.2M | 0.28% |
346,083
+240,113
| +227% | +$9.86M |
|
|
PF
128
DELISTED
Pinnacle Foods, Inc.
PF
| $14.2M | 0.28% |
317,125
+34,275
| +12% | +$1.53M |
|
129
Thermo Fisher Scientific
TMO
$183B
| $13.9M | 0.27% |
97,911
+8,500
| +10% | +$1.2M |
|
130
Colgate-Palmolive
CL
$67.7B
| $13.7M | 0.27% |
193,942
+12,197
| +7% | +$862K |
|
131
Exelon
EXC
$43.8B
| $13.7M | 0.27% |
535,185
+24,232
| +5% | +$620K |
|
132
Citigroup
C
$175B
| $13.6M | 0.27% |
325,576
+71,538
| +28% | +$2.99M |
|
133
Avnet
AVT
$4.38B
| $13.5M | 0.27% |
305,150
-94,176
| -24% | -$4.17M |
|
134
Meta Platforms (Facebook)
META
$1.85T
| $13.4M | 0.26% |
117,291
+27,285
| +30% | +$3.11M |
|
135
Brown & Brown
BRO
$31.4B
| $13.4M | 0.26% |
746,578
+311,816
| +72% | +$5.58M |
|
136
Genpact
G
$7.88B
| $13.3M | 0.26% |
489,486
+63,933
| +15% | +$1.74M |
|
137
Gilead Sciences
GILD
$140B
| $13.2M | 0.26% |
143,917
+1,762
| +1% | +$162K |
|
138
Bio-Rad Laboratories Class A
BIO
$7.8B
| $13.1M | 0.26% |
96,092
+19,551
| +26% | +$2.67M |
|
|
AHL
139
DELISTED
ASPEN Insurance Holding Limited
AHL
| $13.1M | 0.26% |
273,722
+39,852
| +17% | +$1.9M |
|
|
ESRX
140
DELISTED
Express Scripts Holding Company
ESRX
| $13M | 0.26% |
189,879
+167,676
| +755% | +$11.5M |
|
141
Old Republic International
ORI
$10B
| $12.8M | 0.25% |
702,676
+242,579
| +53% | +$4.43M |
|
|
TCF
142
DELISTED
TCF Financial Corporation
TCF
| $12.7M | 0.25% |
1,035,453
-86,549
| -8% | -$1.06M |
|
143
Carnival Corp
CCL
$42.5B
| $12.5M | 0.25% |
236,849
+96,292
| +69% | +$5.08M |
|
144
Carter's
CRI
$1.04B
| $12M | 0.24% |
114,028
+97,310
| +582% | +$10.3M |
|
145
Leidos
LDOS
$22.8B
| $12M | 0.24% |
238,111
-25,307
| -10% | -$1.27M |
|
146
LyondellBasell Industries
LYB
$17.4B
| $11.9M | 0.24% |
139,619
+2,689
| +2% | +$230K |
|
|
PBCT
147
DELISTED
People's United Financial Inc
PBCT
| $11.6M | 0.23% |
729,370
+102,650
| +16% | +$1.64M |
|
148
Jack Henry & Associates
JKHY
$11.8B
| $11.6M | 0.23% |
137,345
-1,306
| -0.9% | -$110K |
|
149
Exxon Mobil
XOM
$477B
| $11.6M | 0.23% |
138,859
-34,420
| -20% | -$2.88M |
|
150
Amgen
AMGN
$153B
| $11.6M | 0.23% |
77,141
+912
| +1% | +$137K |
|